Background: Carcinoma of the breast is one of the most common malignancies of women in our country. The current study was conducted with the objective of assessing Oestrogen receptor (ER) and progesterone receptor (PR) status of carcinoma breast for correlation with age of the patient, tumor dimension, axillary lymph node metastasis and histologic grade. Methodology: One hundred and nineteen female breast cancer patients operated at the surgical oncology department of National Institute of Cancer Research & Hospital were selected by non-probability sampling method and operated specimens were sent for immunohistochemical study of the Oestrogen receptor and progesterone receptors. Statistical analysis was conducted using SPSS version 12 for Windows software. P-value 0.05 or less was considered as significant.
Introduction
Breast cancer is a type of cancer originating from breast tissue, most commonly from the inner lining of milk ducts or the lobules that supply the ducts with milk. Breast cancer is a disease of humans and other mammals; while the overwhelming majority of cases in humans are women, men can sometimes also develop breast cancer 1 . Breast cancer is by far the most frequent cancer among women with an estimated 1.38 million new cancer cases diagnosed in 2008 (23% of all cancers), and ranks second overall (10.9% of all cancers). It is now the most common cancer both in developed and developing regions with around 690 000 new cases estimated in each region 2 . The primary risk factors for breast cancer are female sex, age, lack of childbearing or breastfeeding, higher hormone levels, race and economic status+". The genes associated with hereditary breast-ovarian cancer syndromes usually increase the risk slightly or moderately; the exception is women and men who are carriers of BRCA mutations. These people have a very high lifetime risk for breast and ovarian cancer, depending on the portion of the proteins where the mutation occurs. Instead of a 12 percent lifetime risk of breast cancer, women with one of these genes have 60 percent risk on an average 5 . In more recent years, research has indicated the impact of diet and other behaviors on breast cancer. These additional risk factors include a high-fat diet, alcohol intake, obesity, and environmental factors such as tobacco use, radiation, endocrine disruptors and shiftwork 6 . Estrogen and progesterone receptors (ER, PR) with increasing importance influenced the management of the malignancy 7 . With an established positive correlation of ER and PR with the degree of tumor differentiation, determination of ER and PR status on biopsy specimens prior to therapeutic intervention is advocated as standard practice 8 . The presence of hormone receptors (ER and PR) in the tumor tissue correlates well with the response to hormone therapy 9 . Tumors that are better differentiated are more likely to be ER and PR positive and have a relatively better prognosis 10 -11 . PR is a surrogate marker of a functional ER and as valuable in predicting the behavior of breast carcinoma. It is expressed in 60-70% invasive breast carcinomas with a higher positivity in older age and postmenopausal women. Loss of PR by tumor cells is associated with a worse prognosis 12 . Patients with larger tumors, poorly differentiated morphology, increased number of axillary lymph node metastases and higher stage tumors have more chance of an ER and PR negative status 13 . With the dramatic improvement in our understanding of steroid hormone receptor and prognosis of the patient, determination of estrogen and progesterone receptor status has become a standard practice in the treatment of breast cancer.
Materials and Methods
This cross-sectional observation study was carried out in the department of Surgical Oncology of N ICRH from January 2009 to October 2010. The study was approved by the Ethical Review Committee of NICRH and informed consent was taken from each patient before their enrollment in the study. One hundred and nineteen newly diagnosed female breast cancer patients were enrolled in the study. Sampling was convenient and purposive. The specimen or block of tissue was sent for immunohistochemical examination to specialized diagnostic centers.
Results
Statistical analysis was conducted using SPSS version 12 for Windows software. Continuous data were expressed in mean±SD. Parametric data were evaluated by independent sample "t" test & categorical data were evaluated by Chi-squre ( + 2 ) test as needed. Level of significance for all analytical tests was set as 0.05 & p=d"0.05 was considered significant. Majority of the patients (61, 51 .3%) expressed both the receptors in their breast tissue while 51 (42.9%) patients were both receptors negative. Only a handful number of patients had ER +ve but PR-ve (4.2%) or vice versa ( 1 . 7%) receptor expression. Most patients (85.7%)were pre-menopausal(< 50 year), the median age was 60 years. Patients of 50 years or less expressed ER and PR almost identically (52 and 51 % respectively). Older patients expressed more ER marker than PR (76.5 and 64. 7% respectively). These differences, however, were not statistically significant (Table 1 ) . Table 1 also showed distribution of patients by tumour dimension and receptors status. It was found that.52 (78.8%) of the ER+ patients had tumour dimension equal or less than 5 cm while 14 (21.2%) of the ER+ patients had tumour dimension more than 5 cm. Fifty (79.4%) PR + patients had tumour dimension equal or less than 5 cm and 13 (20.6%) ER + patients had tumour dimension more than 5 cm. From table 1 it is evident that patients (35, 29.4%) without lymph node metastasis express more Estrogen Receptor than patients with axillary lymph node metastasis (31, 26.1%). This difference is statistically significant (+ 2 = 9.922 (df=1 ); p <0.01 ). Most of the patients had grade II (68, 59.1 % ) tumours followed by grade Ill (39, 33.9%). Only 8 (7%) patients had grade I tumours. Initially, ER and PR reactivity increased with increasing tumour grade, i.e. from grade I to grade II but decreased thereafter, from grade II to grade Ill (Table 1 ) . Table 2 showed distribution of the patients by PR, ER scores and age group. It was found that PR expression increased with increasing age. Patients of 36-50 years age group expressed more of the receptors. Like PR expression, ER expression also increased with increasing age. Patients of 36-50 years age group expressed more of the receptors as well. Most of pre-menopausal patients expressed both the receptors identically but older patients expressed more ER. Patients without axillary lymph node metastasis expressed more ER and PR than patients with lymph node metastasis. Most of the patients had grade II tumours followed by grade Ill. Initially, ER and PR reactivity increased with increasing tumour grade, i.e. from grade I to grade II but decreased thereafter, from grade 11 to grade 111. The present study showed reactivity of steroid receptors more on moderately differentiated tumours.
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In conclusion, it can be said that ER and PR expression increases with increasing age and decreases with increased tumour dimension, increased grade and axillary lymph node metastasis. The use of these receptors markers should be made popular amongst the experts who specially deal with carcinoma breast as these facilities are provided in some specialized centres of Bangladesh at reasonable cost.
